[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341694-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341694-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unveiling-the-potential-of-phytochemicals-to-inhibit-nuclear-receptor-binding-set-domain-protein-2-for-cancer-pharmacophore-screening-molecular-docking-adme-properties-and-molecular-dynamics-simulation-investigations","Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer - Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations","","Nuclear receptor binding SET domain protein 2 (NSD2) significantly contributes to cancer development, making it a promising target for drug discovery. The study investigates natural compounds as selective NSD2 inhibitors using a comprehensive in silico workflow that combines pharmacophore modeling, molecular docking, ADME profiling, and 200-nanosecond molecular dynamics simulations. Pharmacophore screening identified 49,248 SuperNatural 3.0 compounds with acceptable alignment, followed by docking that narrowed to ten candidates based on binding affinity (G score). Top hits showed hydrogen bonding, pi-pi stacking, and hydrophobic contacts in the NSD2 active site, with drug-likeness and stable protein-ligand complexes plus minimal fluctuations, supporting their potential for NSD2-associated cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unveiling-the-potential-of-phytochemicals-to-inhibit-nuclear-receptor-binding-set-domain-protein-2-for-cancer-pharmacophore-screening-molecular-docking-adme-properties-and-molecular-dynamics-simulation-investigations/341694/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unveiling-the-potential-of-phytochemicals-to-inhibit-nuclear-receptor-binding-set-domain-protein-2-for-cancer-pharmacophore-screening-molecular-docking-adme-properties-and-molecular-dynamics-simulation-investigations/341694.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is NSD2 considered an important target for cancer drug discovery?","Question",{"text":63,"@type":64},"NSD2 significantly contributes to cancer development and is linked with the occurrence and progression of different cancer types. Inhibiting NSD2 is therefore explored for therapeutic potential.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What computational methods were used to identify potential NSD2 inhibitors?",{"text":68,"@type":64},"The workflow used pharmacophore modeling, e-pharmacophore screening from the SuperNatural 3.0 database, molecular docking to rank candidates by binding affinity (G score), and molecular dynamics simulations for stability assessment. ADME profiling was also applied to evaluate drug-likeness.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the top candidate compounds evaluated for binding and stability?",{"text":72,"@type":64},"Ligand-residue interactions for the top hits included hydrogen bonds, pi-pi stacking, and hydrophobic contacts within the NSD2 active site in the NSD2-PWWP1 domain. Molecular dynamics simulations for 200 nanoseconds confirmed stable protein-ligand complexes with minimal RMSD and RMSF fluctuations.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341694,1790176884,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","PLOS ONE  \nOPEN ACCESS  \nCitation: Mohamed GA, Abdallah HM, Sindi IA, Ibrahim SRM, Alzain AA (2024) Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer:  \nPharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations. PLoS ONE 19(8):  \ne0308913 . [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0308913  \nEditor: Chandrabose Selvaraj, Saveetha University  \nPoonamallee Campus: SIMATS Deemed University, INDIA  \nReceived: March 13, 2024  \nAccepted: August 2, 2024  \nPublished: August 20, 2024  \nCopyright: © 2024 Mohamed et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All relevant data are within the paper.  \nFunding: The Deanship of Scientific Research (DSR) at King Abdulaziz University (KAU), Jeddah, Saudi Arabia has funded this project, under grant no. (RG-43-166-43) . The funders had no role in  \nRESEARCH ARTICLE  \nUnveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations  \nGamalA. Mohamed1 *, Hossam M. Abdallah1, Ikhlas A. Sindi2, Sabrin R. M. Ibrahim3 *, Abdulrahim A. Alzain4  \n1 Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia, 2 Department of Biology, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia, 3 Department of Chemistry, Preparatory Year Program, Batterjee Medical College, Jeddah, Saudi Arabia, 4 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan  \n* [gahussein@kau.edu.sa](gahussein@kau.edu.sa) (GAM); [sabrin.ibrahim@bmc.edu.sa](sabrin.ibrahim@bmc.edu.sa) (SRMI)  \nAbstract  \nNuclear receptor binding SET domain protein 2 (NSD2) significantly contributes to the development of cancer, making it a promising target for cancer drug discovery. This research explores natural compounds as potential selective inhibitors for NSD2 in cancer treatment. Employing a comprehensive in silico approach, the study utilized pharmacophoremodeling, molecular docking, pharmacokinetic profiling, and molecular dynamics simulations. An e-pharmacophore model-based screening using the first selective and potent ligand bound to NSD2 identified 49,248 natural compounds from the SuperNatural 3.0 database (containing 449,008 molecules) with acceptable alignment with the developed pharmacophore hypotheses. Subsequently, molecular docking was executed to assess the standout compounds which led to the selection of ten candidates that surpassed the reference inhibitor in accordance w the binding affinity expressed as a G score. Ligand-residue interaction analyses of the top three hits (SN0450102, SN0410255, and SN0142336) revealed diverse crucial interactions with the NSD2 active site, including hydrogen bonds, pi-pi stacking, and hydrophobic contacts with key amino acid residues in the NSD2-PWWP1 domain. Pharmacokinetic profiling confirmed the drug-likability for the refined hits, indicating good cellular permeability and minimal blood-brain barrier penetration. Molecular dynamics simulations for 200 nanoseconds affirmed the stability of protein-ligand complexes, with minimal fluctuations in root mean square deviation and root mean square fluctuation analyses. Overall, this study identified promising natural compounds as potential pharmaceutical agents in the treatment of NSD2-associated cancers.  \nstudy design, data collection and analysis, decision to publish.  \nCompeting interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that co","cbCaiem4PPO5HZia","https://ap.wps.com/l/cbCaiem4PPO5HZia","pdf",3428526,"English","# Abstract\n# Introduction\n# Study design, data collection and analysis\n# Competing interests","[{\"question\":\"Why is NSD2 considered an important target for cancer drug discovery?\",\"answer\":\"NSD2 significantly contributes to cancer development and is linked with the occurrence and progression of different cancer types. Inhibiting NSD2 is therefore explored for therapeutic potential.\"},{\"question\":\"What computational methods were used to identify potential NSD2 inhibitors?\",\"answer\":\"The workflow used pharmacophore modeling, e-pharmacophore screening from the SuperNatural 3.0 database, molecular docking to rank candidates by binding affinity (G score), and molecular dynamics simulations for stability assessment. ADME profiling was also applied to evaluate drug-likeness.\"},{\"question\":\"How were the top candidate compounds evaluated for binding and stability?\",\"answer\":\"Ligand-residue interactions for the top hits included hydrogen bonds, pi-pi stacking, and hydrophobic contacts within the NSD2 active site in the NSD2-PWWP1 domain. Molecular dynamics simulations for 200 nanoseconds confirmed stable protein-ligand complexes with minimal RMSD and RMSF fluctuations.\"}]","Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer - Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations | PDF",1790043224,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64899ebc0475d75824c9d012e4d077b7.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b80ac4a0b4379b99488eaefc22bbfd07.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfd8e471f8d6e8c6c556a31fa83a75f7.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0efa993ae1f5da79faacc51ae85dea33.webp",980,1268]